About the Company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders. BMS's primary research and development (R&D) sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Hyderabad; Bangalore India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BMY News
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions
To get a sense of who is truly in control of Bristol-Myers Squibb Company ( NYSE:BMY ), it is important to understand the ...
Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S ...
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Bristol Myers Squibb (BMY) ended the recent trading session at $48.51, demonstrating a +0.48% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily ...
The -12.17% Simple Moving Average of Bristol-Myers Squibb Co.’s (BMY) Stock in the Past 200 Days
Based on Bristol-Myers Squibb Co. (BMY), the company’s capital structure generated 0.58 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33. The debt to equity ratio ...
Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Bristol Myers Squibb's share price remains stagnant despite regulatory approvals for innovative drugs. Click here to read an ...
A Closer Look At Bristol-Myers Squibb Company's (NYSE:BMY) Impressive ROE
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...
Bristol Myers Squibb’s Irish outfit pays €15.5bn in dividends over three years
A Dublin based unit of pharma giant, Bristol Myers Squibb last year paid out dividends of just under €6 billion ($6.3 billion ...
Bristol-Myers Squibb Co BMY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is a global biopharmaceutical firm focused on discovering, developing, and delivering innovative medicines for a range of serious diseases. With a rich history dating ...
Bristol Myers Squibb's Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation
Monday, Bristol Myers Squibb & Co (NYSE:BMY) released data from the cohorts of the Phase 1/ 2 KRYSTAL-1 study evaluating ...
Building a Better Future: Bristol Myers Squibb 2023 ESG Report
BMS has enabled positive change for patients around the world, and I am honored to continue this legacy as Board Chair and CEO. Our obligation to advance this legacy is profound.
Bristol-Myers Squibb Co
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...